The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial

EBioMedicine

Volumn 13, Issue , 2016, Pages 348-355

  Okebe, Joseph ^a,e   Bousema, Teun ^b,c   Affara, Muna ^a   Di Tanna, Gian Luca ^d   Dabira, Edgard ^a   Gaye, Abdoulaye ^a   Sanya Isijola, Frank ^a   Badji, Henry ^a   Correa, Simon ^a   Nwakanma, Davis ^a   Van Geertruyden, Jean Pierre ^e   Drakeley, Chris ^b   D'Alessandro, Umberto ^a,b,f  

^a Medical Research Council Unit   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Asymptomatic infection; Efficacy; Gametocyte carriage; Infectivity; Malaria; Plasmodium falciparum; Primaquine; Randomized trial

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE; HEMOGLOBIN; PRIMAQUINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROARTEMISININ; PIPERAQUINE; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; GAMBIA; GAMETOCYTE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MENINGITIS; PALLOR; PLASMODIUM FALCIPARUM; PNEUMONIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SINGLE DRUG DOSE; SKIN INFECTION; TREATMENT OUTCOME; VOMITING; ASYMPTOMATIC DISEASE; CLINICAL TRIAL; COMBINATION DRUG THERAPY; HETEROZYGOTE; MALARIA, FALCIPARUM; PARASITOLOGY;

ADOLESCENT; ANTIMALARIALS; ARTEMISININS; ASYMPTOMATIC DISEASES; CARRIER STATE; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GAMBIA; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIMAQUINE; QUINOLINES; TREATMENT OUTCOME;

EID: 85006039319     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.10.032     Document Type: Article

References (43)

1. Alves, F., Gil, L., Marrelli, M., Ribolla, P., Camargo, E., Da silva, L., Asymptomatic carriers of Plasmodium sp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J. Med. Entomol. 42 (2005), 777–779.
2. Ashley, E.A., Recht, J., White, N.J., Primaquine: the risks and the benefits. Malar. J., 13, 2014, 418.
3. Bennett, J.W., Pybus, B.S., Yadava, A., Tosh, D., Sousa, J.C., Mccarthy, W.F., Deye, G., Melendez, V., Ockenhouse, C.F., Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N. Engl. J. Med. 369 (2013), 1381–1382.
4. Bereczky, S., Montgomery, S.M., Troye-blomberg, M., Rooth, I., Shaw, M.A., Farnert, A., Elevated anti-malarial IgE in asymptomatic individuals is associated with reduced risk for subsequent clinical malaria. Int. J. Parasitol. 34 (2004), 935–942.
5. Bousema, T., Dinglasan, R.R., Morlais, I., Gouagna, L.C., Van Warmerdam, T., Awono-Ambene, P.H., Bonnet, S., Diallo, M., Coulibaly, M., Tchuinkam, T., Mulder, B., Targett, G., Drakeley, C., Sutherland, C., Robert, V., Doumbo, O., Touré, Y., Graves, P.M., Roeffen, W., Sauerwein, R., Birkett, A., Locke, E., Morin, M., Wu, Y., Churcher, T.S., Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PLoS One, 7, 2012, e42821.
6. Bousema, T., Okell, L., Shekalaghe, S., Griffin, J.T., Omar, S., Sawa, P., Sutherland, C., Sauerwein, R., Ghani, A.C., Drakeley, C., Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar. J., 9, 2010, 136.
7. Chotivanich, K., Sattabongkot, J., Udomsangpetch, R., Looareesuwan, S., Day, N.P., Coleman, R.E., White, N.J., Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob. Agents Chemother. 50 (2006), 1927–1930.
8. Dicko, A., Brown, J.M., Diawara, H., Baber, I., Mahamar, A., Soumare, H.M., Sanogo, K., Koita, F., Keita, S., Traore, S.F., Chen, I., Poirot, E., Hwang, J., Mcculloch, C., Lanke, K., Pett, H., Niemi, M., Nosten, F., Bousema, T., Gosling, R., Primaquine to Reduce Transmission of Plasmodium falciparum Malaria in Mali: A Single-blind, Dose-ranging, Adaptive Randomised Phase 2 Trial. 2016 (Lancet Infect Dis).
9. Ekvall, H., Premji, Z., Bennett, S., Bjorkman, A., Hemoglobin concentration in children in a malaria holoendemic area is determined by cumulated Plasmodium falciparum parasite densities. Am.J.Trop. Med. Hyg. 64 (2001), 58–66.
10. El-Sayed, B., El-Zaki, S.E., Babiker, H., Gadalla, N., Ageep, T., Mansour, F., Baraka, O., Milligan, P., Babiker, A., A randomized open-label trial of artesunate - sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. PLoS One, 2, 2007, e1311.
11. Eziefula, A.C., Bousema, T., Yeung, S., Kamya, M., Owaraganise, A., Gabagaya, G., Bradley, J., Grignard, L., Lanke, K.H., Wanzira, H., Mpimbaza, A., Nsobya, S., White, N.J., Webb, E.L., Staedke, S.G., Drakeley, C., Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. Lancet Infect. Dis. 14 (2014), 130–139.
12. Eziefula, A.C., Gosling, R., Hwang, J., Hsiang, M.S., Bousema, T., Von Seidlein, L., Drakeley, C., Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar. J., 11, 2012, 360.
13. Eziefula, A.C., Pett, H., Grignard, L., Opus, S., Kiggundu, M., Kamya, M.R., Yeung, S., Staedke, S.G., Bousema, T., Drakeley, C., Glucose-6-phosphate dehydrogenase status and risk of hemolysis in Plasmodium falciparum-infected African children receiving single-dose primaquine. Antimicrob. Agents Chemother. 58 (2014), 4971–4973.
14. Global Malaria Programme, World Health Organization, WHO policy brief on single-dose primaquine as gametocytocide in Plasmodium falciparum malaria [Online]. Available: http://www.who.int/malaria/publications/atoz/who_htm_gmp_2015.1.pdf, 2015 (Accessed 15th December 2015).
15. Goncalves, B.P., Tiono, A.B., Ouedraogo, A., Guelbeogo, W.M., Bradley, J., Nebie, I., Siaka, D., Lanke, K., Eziefula, A.C., Diarra, A., Pett, H., Bougouma, E.C., Sirima, S.B., Drakeley, C., Bousema, T., Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial. BMC Med., 14, 2016, 40.
16. Howes, R.E., Piel, F.B., Patil, A.P., Nyangiri, O.A., Gething, P.W., Dewi, M., Hogg, M.M., Battle, K.E., Padilla, C.D., Baird, J.K., Hay, S.I., G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med., 9, 2012, e1001339.
17. Imwong, M., Stepniewska, K., Tripura, R., Peto, T.J., Lwin, K.M., Vihokhern, B., Wongsaen, K., Von Seidlein, L., Dhorda, M., Snounou, G., Keereecharoen, L., Singhasivanon, P., Sirithiranont, P., Chalk, J., Nguon, C., Day, N.P., Nosten, F., Dondorp, A., White, N.J., Numerical distributions of parasite densities during asymptomatic malaria. J. Infect. Dis. 213 (2016), 1322–1329.
18. Johnston, G.L., Gething, P.W., Hay, S.I., Smith, D.L., Fidock, D.A., Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination. PLoS Comput. Biol., 10, 2014, e1003434.
19. Karunajeewa, H.A., Mueller, I., How important is gametocyte clearance after malaria therapy?. BMC Med., 14, 2016, 93.
20. Laishram, D., Sutton, P., Nanda, N., Sharma, V., Sobti, R., Carlton, J., Joshi, H., The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar. J., 11, 2012, 29.
21. Mwesigwa, J., Okebe, J., Affara, M., Di Tanna, G.L., Nwakanma, D., Janha, O., Opondo, K., Grietens, K.P., Achan, J., D'alessandro, U., On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey. Malar. J., 14, 2015, 314.
22. Nkhoma, E.T., Poole, C., Vannappagari, V., Hall, S.A., Beutler, E., The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol. Dis. 42 (2009), 267–278.
23. Okebe, J., Bousema, T., Affara, M., Ditanna, G., Eziefula, A.C., Jawara, M., Nwakanma, D., Amambua-Ngwa, A., Van Geertruyden, J.P., Drakeley, C., D'alessandro, U., The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial. Trials, 16, 2015, 70.
24. Okell, L.C., Griffin, J.T., Kleinschmidt, I., Hollingsworth, T.D., Churcher, T.S., White, M.J., Bousema, T., Drakeley, C.J., Ghani, A.C., The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One, 6, 2011, e20179.
25. Ouédraogo, A.L., Guelbéogo, W.M., Cohuet, A., Morlais, I., King, J.G., Gonçalves, B.P., Bastiaens, G.J.H., Vaanhold, M., Sattabongkot, J., Wu, Y., Coulibaly, M., Ibrahima, B., Jones, S., Morin, M., Drakeley, C., Dinglasan, R.R., Bousema, T., Methodology: a protocol for membrane feeding assays to determine the infectiousness of P. falciparum naturally infected individuals to Anopheles gambiae. Malaria World J., 2013, 4.
26. Price, R., Nosten, F., Simpson, J.A., Luxemburger, C., Phaipun, L., Ter Kuile, F., Van Vugt, M., Chongsuphajaisiddhi, T., White, N.J., Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am.J.Trop. Med. Hyg. 60 (1999), 1019–1023.
27. Rigby, R.A., Stasinopoulos, D.M., Smooth centile curves for skew and kurtotic data modelled using the Box-Cox power exponential distribution. Statist. Med. 23 (2004), 3053–3076.
28. Schneider, P., Schoone, G., Schallig, H., Verhage, D., Telgt, D., Eling, W., Sauerwein, R., Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol. Biochem. Parasitol. 137 (2004), 35–41.
29. Shekalaghe, S., Drakeley, C., Gosling, R., Ndaro, A., Van Meegeren, M., Enevold, A., Alifrangis, M., Mosha, F., Sauerwein, R., Bousema, T., Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS One, 2, 2007, e1023.
30. Shekalaghe, S.A., Drakeley, C., Van Den Bosch, S., Ter Braak, R., Van Den Bijllaardt, W., Mwanziva, C., Semvua, S., Masokoto, A., Mosha, F., Teelen, K., Hermsen, R., Okell, L., Gosling, R., Sauerwein, R., Bousema, T., A cluster-randomized trial of mass drug administration with a gametocytocidal drug combination to interrupt malaria transmission in a low endemic area in Tanzania. Malar. J., 10, 2011, 247.
31. Shekalaghe, S.A., Ter Braak, R., Daou, M., Kavishe, R., Van Den Bijllaardt, W., Van Den Bosch, S., Koenderink, J.B., Luty, A.J., Whitty, C.J., Drakeley, C., Sauerwein, R.W., Bousema, T., In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob. Agents Chemother. 54 (2010), 1762–1768.
32. Slater, H.C., Ross, A., Ouedraogo, A.L., White, L.J., Nguon, C., Walker, P.G., Ngor, P., Aguas, R., Silal, S.P., Dondorp, A.M., La Barre, P., Burton, R., Sauerwein, R.W., Drakeley, C., Smith, T.A., Bousema, T., Ghani, A.C., Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies. Nature 528 (2015), S94–101.
33. Smith, T.G., Lourenco, P., Carter, R., Walliker, D., Ranford-Cartwright, L.C., Commitment to sexual differentiation in the human malaria parasite, Plasmodium falciparum. Parasitology 121:Pt 2 (2000), 127–133.
34. Smithuis, F., Kyaw, M.K., Phe, O., Win, T., Aung, P.P., Oo, A.P., Naing, A.L., Nyo, M.Y., Myint, N.Z., Imwong, M., Ashley, E., Lee, S.J., White, N.J., Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Lancet Infect. Dis. 10 (2010), 673–681.
35. STasinopoulos, D.M., Rigby, R.A., Generalized additive models for location scale and shape (GAMLSS) in R. J. Stat. Softw., 2007, 23.
36. Stepniewska, K., Price, R.N., Sutherland, C.J., Drakeley, C.J., Von Seidlein, L., Nosten, F., White, N.J., Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar. J., 7, 2008, 249.
37. Von Seidlein, L., Walraven, G., Milligan, P.J., Alexander, N., Manneh, F., Deen, J.L., Coleman, R., Jawara, M., Lindsay, S.W., Drakeley, C., De Martin, S., Olliaro, P., Bennett, S., Schim Van Der Loeff, M., OKUNOYE, K., TARGETT, G.A., MCADAM, K.P., DOHERTY, J.F., GREENWOOD, B.M., PINDER, M., The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 97 (2003), 217–225.
38. White, N., The role of anti-malarial drugs in eliminating malaria. Malar. J., 7, 2008, S8.
39. WHITE, N., QIAO, L., QI, G., LUZZATTO, L., Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar. J., 11, 2012, 418.
40. White, N.J., Primaquine to prevent transmission of falciparum malaria. Lancet Infect. Dis. 13 (2013), 175–181.
41. White, N.J., Ashley, E.A., Recht, J., Delves, M.J., Ruecker, A., Smithuis, F.M., Eziefula, A.C., Bousema, T., Drakeley, C., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Prachumsri, J., Chu, C., Andolina, C., Bancone, G., HIEN, T.T., MAYXAY, M., TAYLOR, W.R., Von Seidlein, L., Price, R.N., Barnes, K.I., Djimde, A., Ter Kuile, F., Gosling, R., Chen, I., Dhorda, M.J., Stepniewska, K., Guerin, P., Woodrow, C.J., Dondorp, A.M., DAY, N.P., Nosten, F.H., Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria. Malar. J., 13, 2014, 483.
42. World Health Organization, Guidelines for the Treatment of Malaria. 2010, World Health Organization, Geneva.
43. WWARN Gametocyte Study Group, Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med, 14, 2016, 79.